FDA considers yanking nicotine vaping pods off the market as it fights a surge in teen vaping
, at the same time that the companies had promised to increase efforts to keep kids from getting hooked on e-cigarettes. Miffed by the transaction, Gottlieb had summoned the companies to Washington to provide answers.
Gottlieb said the FDA is working on defining exactly what constitutes a pod-based product in case it needs to temporarily ban them. Sales of vaping pods could resume if manufacturers show that their devices are geared toward adult cigarette smokers trying to quit, and not kids. “The FDA is going to have to very carefully calculate its action against the entire category of pod-based products,” Gottlieb said.
Separately, San Francisco officials proposed legislation Tuesday that would forbid the sale of e-cigarettes in the city and ban companies such as Juul from occupying city-owned property, the San Francisco ChronicleThe FDA last week released a draft guideline on its much-anticipated plan to limit the sales of most flavored e-cigarettes.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA tightens restrictions on e-cigarette sales and fruity flavors to stem teen vapingFDA tightens restrictions on e-cigarette sales and fruity flavors to stem teen vaping.
Leer más »
FDA considers yanking nicotine vaping pods off the marketU.S. Food and Drug Administration Commissioner Scott Gottlieb said Tuesday that his agency may need to pull pod-based nicotine products off the market as it fights a surge in teen vaping.
Leer más »
The US just launched a crackdown on flavored e-cigs and cigars in a huge move to fight smokingThe anti-vaping proposals come a week after FDA Commissioner Scott Gottlieb announced his plans to step down.
Leer más »
U.S. proposes stricter curbs on e-cigarette salesThe U.S. Food and Drug Administration (FDA) on Wednesday released formal plans t...
Leer más »
FDA puts partial hold on clinical trials of AbbVie's cancer drugAbbVie Inc said on Tuesday the U.S. Food and Drug Administration placed a partia...
Leer más »
Sage Therapeutics’ Drug for Postpartum Depression Gets FDA NodU.S. health regulators on Tuesday approved Sage Therapeutics Inc.’s Zulresso, the first medication specifically intended for women with postpartum depression.
Leer más »
J&J and Sientra get FDA warning letters for breast implantsThe U.S. Food and Drug Administration has issued warning letters to Sientra Inc ...
Leer más »
Sage stock rises after FDA approves first postpartum depression treatment Zulresso
Leer más »